Chromatin and Epigenetics
May 1, 2019 - May 4, 2019
Conference Overview
Epigenetics refers to heritable change in gene expression that does not involve changes to the underlying DNA sequence. At least three systems including DNA methylation, histone modifications and non-coding RNAs (ncRNA) are considered to play fundamental roles in epigenetic regulation. Research over the last two decades has uncovered the role of epigenetics in a variety of human disorders and fatal diseases. Moreover influence of age, environment, lifestyle, and disease state on epigenetic states is being increasingly appreciated and actively studied.
This conference provides an international forum for cutting edge research in chromatin and epigenetics. It provides the “focal hub” for people to present their research and exchange ideas in a European venue. Renowned speakers will cover the latest advances in the field, including chromatin regulation, chromatin dynamics, signalling to chromatin, nuclear architecture and dynamics, developmental epigenetics, epigenomics, epigenetics and human diseases, genome stability, environmental epigenetics, and transgenerational inheritance.
Session Topics
- Epigenetic reprogramming
- Developmental epigenetics
- Different states of chromatin
- Histone modifications, RNA and metabolism
- Transcriptional and posttranscriptional regulation
- Nuclear architecture
- Chromatin and its variants in disease
Speakers:
Asifa Akhtar
Max Planck Institute of Immunobiology and Epigenetics, Germany
Geneviève Almouzni
Institut Curie, France
Wendy Bickmore
The University of Edinburgh, UK
Andrea Brand
The Gurdon Institute, University of Cambridge, UK
Howard Y. Chang
Stanford University, USA
L. Stirling Churchman
Harvard Medical School, USA
Ibrahim Cissé
Massachusetts Institute of Technology, USA
Xavier Darzacq
University of California, Berkeley, USA
Caroline Dean
John Innes Centre, UK
Joseph R. Ecker
HHMI & The Salk Institute for Biological Studies, USA
Emma Farley
University of California, San Diego, USA
Anne Ferguson-Smith
University of Cambridge, UK
Polly Fordyce
Stanford University, USA
Eileen Furlong
EMBL Heidelberg, Germany
Edith Heard
EMBL Heidelberg, Germany
Steven Henikoff
Fred Hutchinson Cancer Research Center, USA
Gary H. Karpen
UC Berkeley, Lawrence Berkeley National Lab, USA
Jean-Christophe Marine
VIB-KU Leuven Center for Cancer Biology, Belgium
Ana Pombo
Max Delbrück Center for Molecular Medicine, Germany
Chris Ponting
The University of Edinburgh, UK
Wolf Reik
Babraham Institute, UK
Amos Tanay
Weizmann Institute of Science, Israel
Igor Ulitsky
Weizmann Institute of Science, Israel
Fred Winston
Harvard Medical School, USA